Clinical Trial Update: Injection of ex Vivo Amplified G-CSF Mobilised Autologous Peripheral Blood Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ex vivo amplified G-CSF-mobilised autologous peripheral blood stem cell transplantation in multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Filgrastim (filgrastim)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED